Overall, we have demonstrated that although levels of GLI3 are enhanced in models of ARPKD, dampening this upregulation does not alter cyst progression or spheroid size in mouse and human models respectively, highlighting the functional complexity of the Hh pathway in ARPKD. The gene discussed is GLI3; the disease is cyst.